193 related articles for article (PubMed ID: 15758839)
1. Characteristics of autoimmune thyroid disease occurring as a late complication of immune reconstitution in patients with advanced human immunodeficiency virus (HIV) disease.
Chen F; Day SL; Metcalfe RA; Sethi G; Kapembwa MS; Brook MG; Churchill D; de Ruiter A; Robinson S; Lacey CJ; Weetman AP
Medicine (Baltimore); 2005 Mar; 84(2):98-106. PubMed ID: 15758839
[TBL] [Abstract][Full Text] [Related]
2. Sequential occurrence of thyroid autoantibodies and Graves' disease after immune restoration in severely immunocompromised human immunodeficiency virus-1-infected patients.
Jubault V; Penfornis A; Schillo F; Hoen B; Izembart M; Timsit J; Kazatchkine MD; Gilquin J; Viard JP
J Clin Endocrinol Metab; 2000 Nov; 85(11):4254-7. PubMed ID: 11095463
[TBL] [Abstract][Full Text] [Related]
3. Repeated presentation of Graves' disease as a manifestation of immune reconstitution syndrome in an HIV-infected patient taking HAART: case report.
Visković K; Stemberger L; Brnić Z; Begovac J
Acta Clin Croat; 2013 Mar; 52(1):125-7. PubMed ID: 23837283
[TBL] [Abstract][Full Text] [Related]
4. Graves' disease during immune reconstitution after highly active antiretroviral therapy for HIV infection: evidence of thymic dysfunction.
French MA; Lewin SR; Dykstra C; Krueger R; Price P; Leedman PJ
AIDS Res Hum Retroviruses; 2004 Feb; 20(2):157-62. PubMed ID: 15018703
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of thyroid function and autoimmunity in HIV-infected women.
Carvalho LG; Teixeira Pde F; Panico AL; Cohen MV; Pinheiro MF; Barroso PF; Vaisman M
Arq Bras Endocrinol Metabol; 2013 Aug; 57(6):450-6. PubMed ID: 24030185
[TBL] [Abstract][Full Text] [Related]
6. Thyroid function in human immunodeficiency virus patients treated with highly active antiretroviral therapy (HAART): a longitudinal study.
Madeddu G; Spanu A; Chessa F; Calia GM; Lovigu C; Solinas P; Mannazzu M; Falchi A; Mura MS; Madeddu G
Clin Endocrinol (Oxf); 2006 Apr; 64(4):375-83. PubMed ID: 16584508
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of the effectiveness of highly active antiretroviral therapy in persons with human immunodeficiency virus using biomarker-based equivalence of disease progression.
Jacobson LP; Li R; Phair J; Margolick JB; Rinaldo CR; Detels R; Muñoz A
Am J Epidemiol; 2002 Apr; 155(8):760-70. PubMed ID: 11943695
[TBL] [Abstract][Full Text] [Related]
8. Long-term clinical benefit after highly active antiretroviral therapy in advanced HIV-1 infection, even in patients without immune reconstitution.
Arici C; Ripamonti D; Ravasio V; Maggiolo F; Rizzi M; Finazzi MG; Suter F
Int J STD AIDS; 2001 Sep; 12(9):573-81. PubMed ID: 11516366
[TBL] [Abstract][Full Text] [Related]
9. Role of hepatitis C virus (HCV) viremia and HCV genotype in the immune recovery from highly active antiretroviral therapy in a cohort of antiretroviral-naive HIV-infected individuals.
Antonucci G; Girardi E; Cozzi-Lepri A; Capobianchi MR; De Luca A; Puoti M; Petrelli E; Carnevale G; Rizzardini G; Grossi PA; Viganò P; Moioli MC; Carletti F; Solmone M; Ippolito G; Monforte AD; ;
Clin Infect Dis; 2005 Jun; 40(12):e101-9. PubMed ID: 15909251
[TBL] [Abstract][Full Text] [Related]
10. Rapid CD4 decline prior to antiretroviral therapy predicts subsequent failure to reconstitute despite HIV viral suppression.
Darraj M; Shafer LA; Chan S; Kasper K; Keynan Y
J Infect Public Health; 2018; 11(2):265-269. PubMed ID: 28826735
[TBL] [Abstract][Full Text] [Related]
11. Graves' disease during immune reconstitution in HIV-infected patients treated with HAART.
Vos F; Pieters G; Keuter M; van der Ven A
Scand J Infect Dis; 2006; 38(2):124-6. PubMed ID: 16449004
[TBL] [Abstract][Full Text] [Related]
12. Association of Body Composition and Other Clinical Factors with Incomplete Immune Response after Highly Active Antiretroviral Therapy.
Sun PT; Yu W; Li TS; Lin Q; Guo FP; Zhou XH; Du GY; Xu Y; Guan WM
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2017 Aug; 39(4):459-464. PubMed ID: 28877821
[TBL] [Abstract][Full Text] [Related]
13. Delayed progression to death and to AIDS in a Hong Kong cohort of patients with advanced HIV type 1 disease during the era of highly active antiretroviral therapy.
Wong KH; Chan KC; Lee SS
Clin Infect Dis; 2004 Sep; 39(6):853-60. PubMed ID: 15472819
[TBL] [Abstract][Full Text] [Related]
14. HIV and autoimmunity.
Zandman-Goddard G; Shoenfeld Y
Autoimmun Rev; 2002 Dec; 1(6):329-37. PubMed ID: 12848988
[TBL] [Abstract][Full Text] [Related]
15. CD4+ cell count, viral load, and highly active antiretroviral therapy use are independent predictors of body composition alterations in HIV-infected adults: a longitudinal study.
McDermott AY; Terrin N; Wanke C; Skinner S; Tchetgen E; Shevitz AH
Clin Infect Dis; 2005 Dec; 41(11):1662-70. PubMed ID: 16267741
[TBL] [Abstract][Full Text] [Related]
16. Graves' disease after interleukin-2 therapy in a patient with human immunodeficiency virus infection.
Jimenez C; Moran SA; Sereti I; Wynne S; Yen PM; Falloon J; Davey RT; Sarlis NJ
Thyroid; 2004 Dec; 14(12):1097-102. PubMed ID: 15650365
[TBL] [Abstract][Full Text] [Related]
17. Graves' disease as an immune reconstitution syndrome in an HIV-1-positive patient commencing effective antiretroviral therapy: case report and literature review.
Knysz B; Bolanowski M; Klimczak M; Gladysz A; Zwolinska K
Viral Immunol; 2006; 19(1):102-7. PubMed ID: 16553555
[TBL] [Abstract][Full Text] [Related]
18. The predictive role of CD4
Li CX; Li YY; He LP; Kou J; Bai JS; Liu J; Tian B; Cao LJ; Wang KH; Kuang YQ
BMC Immunol; 2019 Aug; 20(1):31. PubMed ID: 31455209
[TBL] [Abstract][Full Text] [Related]
19. [The clinical significance of serum autoantibodies and HLA-B(27) molecule testing in Uygur patients with human immunodeficiency virus infection].
Chen XM; Luo CN; Wu LJ; Shi YM; Wu X; Meng XY; Lei X; Liu Y; Reyimujiang Y; Gulimire K; Wang TY; Xia FF
Zhonghua Nei Ke Za Zhi; 2020 Mar; 59(3):195-199. PubMed ID: 32146745
[No Abstract] [Full Text] [Related]
20. Immune reconstitution inflammatory syndrome in adult human immunodeficiency virus-infected patients in Thailand.
Aramaki M; Silachamroon U; Desakorn V; Maek-A-nantawat W; Waiwaruwut J; Jutiwarakun K; Kim JH; Pitisuttithum P
Southeast Asian J Trop Med Public Health; 2010 Jan; 41(1):138-45. PubMed ID: 20578492
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
